Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy.
Nat Cancer
; 2(6): 658-671, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-34712959
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
Limits:
Female
/
Humans
Language:
En
Year:
2021
Type:
Article